These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34895656)

  • 1. Recent advances in self-adjuvanting glycoconjugate vaccines.
    Manabe Y; Chang TC; Fukase K
    Drug Discov Today Technol; 2020 Dec; 37():61-71. PubMed ID: 34895656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative Vaccine Strategy: Self-Adjuvanting Conjugate Vaccines.
    Manabe Y; Fukase K
    Methods Mol Biol; 2023; 2613():55-72. PubMed ID: 36587070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines.
    Li Q; Guo Z
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29966261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccine.
    Xu Z; Rivera-Hernandez T; Chatterjee O; Walker MJ; Moyle PM
    J Control Release; 2020 Jan; 317():96-108. PubMed ID: 31758971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
    Moyle PM
    Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological Evaluation of Co-Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidates.
    Aiga T; Manabe Y; Ito K; Chang TC; Kabayama K; Ohshima S; Kametani Y; Miura A; Furukawa H; Inaba H; Matsuura K; Fukase K
    Angew Chem Int Ed Engl; 2020 Sep; 59(40):17705-17711. PubMed ID: 32583549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-adjuvanting cancer nanovaccines.
    Liao Z; Huang J; Lo PC; Lovell JF; Jin H; Yang K
    J Nanobiotechnology; 2022 Jul; 20(1):345. PubMed ID: 35883176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of polymer-based particulate vaccine adjuvants.
    Huete-Carrasco J; Lynch RI; Ward RW; Lavelle EC
    Eur J Immunol; 2024 Feb; 54(2):e2350512. PubMed ID: 37994660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope.
    Chang TC; Manabe Y; Ito K; Yamamoto R; Kabayama K; Ohshima S; Kametani Y; Fujimoto Y; Lin CC; Fukase K
    RSC Adv; 2022 Jun; 12(29):18985-18993. PubMed ID: 35873332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in Vaccine Adjuvants.
    Firdaus FZ; Skwarczynski M; Toth I
    Methods Mol Biol; 2022; 2412():145-178. PubMed ID: 34918245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses.
    Du JJ; Wang CW; Xu WB; Zhang L; Tang YK; Zhou SH; Gao XF; Yang GF; Guo J
    iScience; 2020 Mar; 23(3):100935. PubMed ID: 32146328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of component structural arrangement on peptide vaccine immunogenicity.
    Alharbi N; Skwarczynski M; Toth I
    Biotechnol Adv; 2022 Nov; 60():108029. PubMed ID: 36028180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of synthetic, self-adjuvanting, and self-assembling anticancer vaccines based on a minimal saponin adjuvant and the tumor-associated MUC1 antigen.
    Pifferi C; Aguinagalde L; Ruiz-de-Angulo A; Sacristán N; Baschirotto PT; Poveda A; Jiménez-Barbero J; Anguita J; Fernández-Tejada A
    Chem Sci; 2023 Mar; 14(13):3501-3513. PubMed ID: 37006677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein-Fusion Combination Vaccine.
    Xu Z; Rivera-Hernandez T; Moyle PM
    ACS Infect Dis; 2020 Jul; 6(7):1770-1782. PubMed ID: 32407620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine adjuvants: Tailoring innate recognition to send the right message.
    Lavelle EC; McEntee CP
    Immunity; 2024 Apr; 57(4):772-789. PubMed ID: 38599170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-(4-Amino-2-butyl-imidazoquinolyl)-norleucine: Toll-like receptor 7 and 8 agonist amino acid for self-adjuvanting peptide vaccine.
    Fujita Y; Hirai K; Nishida K; Taguchi H
    Amino Acids; 2016 May; 48(5):1319-29. PubMed ID: 26874701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly stable gold nanoparticle-antigen conjugates with self-adjuvanting property for induction of robust antigen-specific immune responses.
    Lin ZY; Chen YH; Wu YW; Chen MC
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112897. PubMed ID: 36215893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19.
    Wen Y; Zhang RY; Wang J; Zhou SH; Peng XQ; Ding D; Zhang ZM; Wei HW; Guo J
    J Control Release; 2023 Mar; 355():238-247. PubMed ID: 36716860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.